Raynaud's phenomenon: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 15: | Line 15: | ||
{{Raynaud's phenomenon}} | {{Raynaud's phenomenon}} | ||
'''Editors-In-Chief:''' Asghar Fakhri, M.D., Duane S. Pinto, M.D. and C. Michael Gibson, M.S., M.D. | '''Editors-In-Chief:''' Asghar Fakhri, M.D., Duane S. Pinto, M.D. and [[User:C Michael Gibson|C. Michael Gibson, M.S., M.D.]] | ||
==[[Raynaud's phenomenon overview|Overview]]== | ==[[Raynaud's phenomenon overview|Overview]]== |
Revision as of 22:15, 21 August 2012
For patient information click here
Raynaud's phenomenon | |
Hands with Raynaud's phenomenon | |
ICD-10 | I73.0 |
ICD-9 | 443.0 |
DiseasesDB | 25933 |
MeSH | D011928 |
Raynaud's phenomenon Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Raynaud's phenomenon On the Web |
American Roentgen Ray Society Images of Raynaud's phenomenon |
Editors-In-Chief: Asghar Fakhri, M.D., Duane S. Pinto, M.D. and C. Michael Gibson, M.S., M.D.
Overview
Pathophysiology
Causes
Differentiating Raynaud's phenomenon from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Other imaging findings | Other diagnostic studies
Treatment
Medical therapy | Primary prevention | Secondary prevention | Financial costs | Future therapies
See also
External links